Construction and validation of a novel prognostic nomogram for patients with poorly differentiated gastric neuroendocrine neoplasms

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

222

Figures (1-4)

Tables (1-2)

Sum=432

Publishing Process of This Article

Item

Count

Browse

Download

Sum=39

Apr 24, 2025 (publication date) through Apr 27, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Apr 24, 2025; 16(4): 102565
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.102565

Full Size Figure Download Figure

Figure 1 Comparison of overall survival among stage I, stage II, stage III and stage IV patients. OS: Overall survival.

Citation: Zhang BL, Peng F, Li L, Gao YH, Wang ZJ, Lu YX, Chen L, Zhang KC. Construction and validation of a novel prognostic nomogram for patients with poorly differentiated gastric neuroendocrine neoplasms. World J Clin Oncol 2025; 16(4): 102565
URL: https://www.wjgnet.com/2218-4333/full/v16/i4/102565.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i4.102565